Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-21

Clinical Trial Update: Does Guanfacine Attenuate Stress-Induced Drinking? [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating whether guanfacine reduces stress-induced alcohol drinking has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guanfacine (guanfacine)

Snippet

Sponsor: Yale University | Conditions: Alcohol Drinking | Phase 2 | Status: COMPLETED | Results posted: 2021-04-21